Literature DB >> 28446985

Whack-a-mole strategy for multifocal ground glass opacities of the lung.

Kenji Suzuki1.   

Abstract

Ground glass opacity (GGO) is a good prognostic indicator for lung cancer and is useful for physicians to predict prognosis. Due to recent advances in computed tomography (CT), the chance to encounter GGO is rapidly increasing in clinical practice. Based on the studies on radiological pathological correlation, GGO represents pathological lepidic growth and consolidation on CT represents pathologically invasive components. Thus, consolidation tumor ratio 0.5 or less means pathological less invasiveness for lung cancer. Not a few studies have shown that sublobar resection is equivalent to lobectomy for radiological early lung cancers. Additionally, observation of GGO is one of the options for physicians. Indication of surgical intervention remains unclear. Physician observing GGO in practice should know the natural history of GGO to reach an optimal treatment decision. For multifocal GGO lesions clinical management is surely challenging. Whack-a-mole strategy, which means sublobar resection for radiological invasive cancer is one of the most promising strategies for such lesions.

Entities:  

Keywords:  Local recurrence; ground glass opacity (GGO); prognosis; sublobar resection

Year:  2017        PMID: 28446985      PMCID: PMC5392542          DOI: 10.21037/jtd.2017.04.03

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  48 in total

1.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.

Authors:  Ken Kodama; Masahiko Higashiyama; Hideoki Yokouchi; Koji Takami; Keiko Kuriyama; Yoko Kusunoki; Tomio Nakayama; Fumio Imamura
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

2.  Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

5.  Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  K Takamochi; K Nagai; J Yoshida; K Suzuki; Y Ohde; M Nishimura; S Sasaki; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

6.  Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

Authors:  Junji Yoshida; Kanji Nagai; Tomoyuki Yokose; Mitsuyo Nishimura; Ryutaro Kakinuma; Hironobu Ohmatsu; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

7.  Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact.

Authors:  Kenji Suzuki; Masahiko Kusumoto; Shun-ichi Watanabe; Ryosuke Tsuchiya; Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

8.  Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography: Comparison with Solitary Invasive Adenocarcinoma.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  J Thorac Oncol       Date:  2016-01-21       Impact factor: 15.609

9.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

Authors:  Y Shimosato; A Suzuki; T Hashimoto; Y Nishiwaki; T Kodama; T Yoneyama; T Kameya
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

10.  Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.

Authors:  Cristiano Rampinelli; Paolo De Marco; Daniela Origgi; Patrick Maisonneuve; Monica Casiraghi; Giulia Veronesi; Lorenzo Spaggiari; Massimo Bellomi
Journal:  BMJ       Date:  2017-02-08
View more
  6 in total

1.  Bilateral uniportal video-assisted thoracic surgery segmentectomy S3: an unusual case.

Authors:  Alonso José Oviedo Argueta; Sonia Raquelline Roque Cañas; Yuming Zhu; Diego Gonzalez-Rivas
Journal:  J Vis Surg       Date:  2017-11-11

2.  Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management.

Authors:  Gianluca Milanese; Nicola Sverzellati; Ugo Pastorino; Mario Silva
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Establishment and verification of a prediction model based on clinical characteristics and positron emission tomography/computed tomography (PET/CT) parameters for distinguishing malignant from benign ground-glass nodules.

Authors:  Rong Niu; Xiaonan Shao; Xiaoliang Shao; Zhenxing Jiang; Jianfeng Wang; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-05

4.  Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs.

Authors:  Xin Wang; Manqi Wu; Haifeng Shen; Yuntao Nie; Kai Zhang; Zihan Wei; Ziyang Wang; Fan Yang; Kezhong Chen
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

5.  Computed tomography-guided percutaneous microwave ablation: A novel perspective to treat multiple pulmonary ground-glass opacities.

Authors:  Baodong Liu; Xin Ye
Journal:  Thorac Cancer       Date:  2020-08-03       Impact factor: 3.500

6.  A case of a rare non-invasive lung adenocarcinoma.

Authors:  Motoaki Yasukawa; Hiroe Itami; Tomomi Fujii; Shigeki Taniguchi; Chiho Ohbayashi
Journal:  Int J Surg Case Rep       Date:  2020-10-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.